Page last updated: 2024-08-24

lamivudine and ARC

lamivudine has been researched along with ARC in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cameron, J; Cammack, N; Cooley, TP; Gu, Z; Hirst, HM; McCaffrey, R; Montaner, JS; Ruedy, J; Salomon, H; Wainberg, MA	1
Boucher, CA; Cammack, N; Hill, A; Ingrand, D; Loveday, C; Robert, C; Weber, J	1
Deray, G; Izzedine, H; Launay-Vacher, V	1

Trials

2 trial(s) available for lamivudine and ARC

Article	Year
Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex. AIDS (London, England), 1995, Volume: 9, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Complex; Base Sequence; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Lamivudine; Male; Molecular Sequence Data; Mutation; Phenotype; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zalcitabine	1995
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group. AIDS (London, England), 1995, Volume: 9, Issue:12 Topics: Adult; AIDS-Related Complex; Antigen-Antibody Complex; Antiviral Agents; Dose-Response Relationship, Drug; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia; Zalcitabine	1995

Article

Year

Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex.

AIDS (London, England), 1995, Volume: 9, Issue:4

Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Complex; Base Sequence; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Lamivudine; Male; Molecular Sequence Data; Mutation; Phenotype; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zalcitabine

1995

Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.

AIDS (London, England), 1995, Volume: 9, Issue:12

Topics: Adult; AIDS-Related Complex; Antigen-Antibody Complex; Antiviral Agents; Dose-Response Relationship, Drug; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia; Zalcitabine

1995

Other Studies

1 other study(ies) available for lamivudine and ARC

Article	Year
Dosage of lamivudine in a haemodialysis patient. Nephron, 2000, Volume: 86, Issue:4 Topics: Adult; AIDS-Related Complex; Anti-HIV Agents; HIV Infections; Humans; Kidney Failure, Chronic; Lamivudine; Male; Renal Dialysis	2000